OLYMPUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,096 JPY | -5.16% |
|
-2.92% | +2.74% |
| Apr. 08 | Olympus to Return Land and Building to Shenzhen City Government | MT |
| Mar. 28 | Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024 | CI |
| Sales 2024 * | 929B 6B | Sales 2025 * | 988B 6.39B | Capitalization | 2,444B 15.8B |
|---|---|---|---|---|---|
| Net income 2024 * | 259B 1.67B | Net income 2025 * | 110B 711M | EV / Sales 2024 * | 2.57 x |
| Net cash position 2024 * | 57.16B 369M | Net cash position 2025 * | 121B 780M | EV / Sales 2025 * | 2.35 x |
| P/E ratio 2024 * |
9.77
x | P/E ratio 2025 * |
22.7
x | Employees | 32,844 |
| Yield 2024 * |
0.85% | Yield 2025 * |
0.95% | Free-Float | 88.47% |
More Fundamentals
* Assessed data
More news
Latest transcript on Olympus Corporation
More recommendations
More press releases
More news
| 1 day | -5.16% | ||
| 1 week | -2.92% | ||
| Current month | -5.24% | ||
| 1 month | -4.44% | ||
| 3 months | -7.03% | ||
| 6 months | +7.87% | ||
| Current year | +2.74% |
1 week
2 083.00
2 293.00
1 month
2 050.002 293.00
Current year
1 935.502 304.00
1 year
1 782.002 482.50
3 years
1 782.003 198.00
5 years
1 159.003 198.00
10 years
731.753 198.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 56 | 17-03-31 |
Yasuo Takeuchi
CHM | Chairman | 67 | 80-03-31 |
John de Csepel
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jimmy C. Beasley
BRD | Director/Board Member | 61 | 19-05-31 |
Sumitaka Fujita
BRD | Director/Board Member | 81 | 12-03-31 |
Gary Pruden
BRD | Director/Board Member | 61 | 22-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.83% | 31 M€ | +7.88% | ||
| 2.11% | 11 M€ | +8.30% | - | |
| 1.55% | 251 M€ | +13.08% | ||
| 1.23% | 31,732 M€ | +11.76% | - | |
| 1.22% | 1,198 M€ | +11.02% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 2,096 | -5.16% | 10,478,800 |
| 24-04-18 | 2,210 | +0.27% | 3,061,400 |
| 24-04-17 | 2,204 | -1.58% | 3,230,100 |
| 24-04-16 | 2,240 | +2.35% | 5,759,900 |
| 24-04-15 | 2,188 | +1.34% | 3,154,300 |
Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT
More quotes
Olympus Corporation specializes in manufacturing and marketing of optical and photographic equipments. Net sales break down by family of products as follows:
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Calendar
2024-05-09
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,096
JPY
Average target price
2,426
JPY
Spread / Average Target
+15.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.74% | 16.67B | |
| +2.64% | 207B | |
| +1.80% | 175B | |
| +8.59% | 132B | |
| +16.47% | 99.1B | |
| -3.42% | 60.89B | |
| +12.71% | 52.04B | |
| -6.61% | 45.48B | |
| -4.53% | 38.81B | |
| +9.27% | 38.77B |
- Stock Market
- Equities
- 7733 Stock
